Terms: = Liver cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
328 results:
1. liver cancer development driven by the AP-1/c-jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
3. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
4. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
5. Regucalcin downregulation in human cancer.
Ghanem NZ; Yamaguchi M
Life Sci; 2024 Mar; 340():122448. PubMed ID: 38246519
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract] [Full Text] [Related]
7. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
8. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
[TBL] [Abstract] [Full Text] [Related]
9. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
[TBL] [Abstract] [Full Text] [Related]
10. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.
Behrouzi R; Armstrong AC; Howell SJ
Breast Cancer Res Treat; 2023 Nov; 202(1):83-95. PubMed ID: 37584881
[TBL] [Abstract] [Full Text] [Related]
11. CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy.
Song S; Wang L; Jiang X; Liu X; Li S; Xie S; Lu D
Cell Signal; 2023 Sep; 109():110772. PubMed ID: 37321526
[TBL] [Abstract] [Full Text] [Related]
12. Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
Kim MH; Lee EJ; Kim SJ; Jung YJ; Park WJ; Park I
PLoS One; 2023; 18(6):e0287146. PubMed ID: 37310967
[TBL] [Abstract] [Full Text] [Related]
13. Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-jun/ACSL3 in hepatocellular carcinoma.
Lu Y; Liang H; Li X; Chen H; Yang C
Aging (Albany NY); 2023 May; 15(11):4699-4713. PubMed ID: 37294538
[TBL] [Abstract] [Full Text] [Related]
14. Integration of ATAC-Seq and RNA-Seq reveals FOSL2 drives human liver progenitor-like cell aging by regulating inflammatory factors.
Ding M; Huang W; Liu G; Zhai B; Yan H; Zhang Y
BMC Genomics; 2023 May; 24(1):260. PubMed ID: 37173651
[TBL] [Abstract] [Full Text] [Related]
15. MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract] [Full Text] [Related]
16. Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients.
Ullah MA; Alam S; Moin AT; Ahamed T; Shohael AM
Comput Biol Med; 2023 May; 158():106855. PubMed ID: 37040675
[TBL] [Abstract] [Full Text] [Related]
17. Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC.
Zhuo B; Zhang Q; Xie T; Wang Y; Chen Z; Zuo D; Guo B
Cell Mol Life Sci; 2023 Mar; 80(4):103. PubMed ID: 36941472
[TBL] [Abstract] [Full Text] [Related]
18. Multi-Targeted Peptide-Modified Gold Nanoclusters for Treating Solid Tumors in the liver.
Xiao F; Chen Y; Qi J; Yao Q; Xie J; Jiang X
Adv Mater; 2023 May; 35(20):e2210412. PubMed ID: 36863998
[TBL] [Abstract] [Full Text] [Related]
19. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
20. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract] [Full Text] [Related]
[Next]
